Hypertension in HIV-Infected Patients Receiving Antiretroviral Therapy in Northeast Ethiopia

Table 2

Prevalence of hypertension among HIV-infected patients on ART at DRH in Northeast Ethiopia.

Characteristics	Hypertension status		value
	Yes (N = 121), n (%)	No (N = 287), n (%)
Age (years)			<0.001
≤45	79 (23.9)	251 (76.1)
>45 years	42 (53.8)	36 (46.2)
Sex			0.003
Male	53 (39.3)	82 (60.7)
Female	68 (24.9)	205 (75.1)
Residence			0.772
Rural	25 (28.4)	63 (71.6)
Urban	96 (30.0)	224 (70.0)
Education			0.484
<High school	68 (28.3)	172 (71.7)
≥High school	53 (31.5)	115 (68.5)
Duration of HIV infection (years)			0.041
≤5	34 (23.4)	111 (76.6)
>5	87 (33.1)	176 (66.9)
Duration on ART (years)			<0.001
≤5	47 (20.7)	180 (79.3)
>5	74 (40.9)	107 (59.1)
ART regimen			0.911
AZT + 3TC + EFV	17 (25.8)	49 (74.2)
TDF + 3TC + NVP	20 (28.2)	51 (70.2)
AZT + 3TC + NVP	25 (29.8)	59 (70.2)
TDF + 3TC + EFV	25 (32.9)	51 (67.1)
Other	34 (30.6)	77 (69.4)
Smoking			0.887
Yes	5 (31.2)	11 (68.8)
No	116 (29.6)	276 (70.4)
Alcohol use			0.164
Yes	23 (37.1)	39 (62.9)
No	98 (28.3)	248 (71.7)
Family history of hypertension			0.044
Yes	23 (41.1)	33 (58.9)
No	98 (27.8)	254 (72.2)
Body mass index (kg/m^2)			0.011
<25	113 (28.6)	282 (71.4)
≥25	8 (61.5)	5 (38.5)
WHO clinical stage			0.876
Early stage (I and II)	97 (29.5)	232 (70.5)
Advanced stage (III and IV)	24 (30.4)	55 (69.5)
CD4 count (cells/mm^3)			0.020
<350	86 (33.7)	169 (66.3)
≥350	35 (22.9)	118 (77.1)
Diabetes mellitus			<0.001
Yes	21 (58.3)	15 (41.7)
No	100 (26.9)	272 (73.1)
Glomerular filtration rate (ml/min/1.73 m^2)			0.005
<60	18 (45.0)	22 (55.0)
60–89.9	27 (39.7)	41 (60.3)
≥90	76 (25.3)	224 (74.7)